Annual EBITDA
$1.02B$73.08M+7.69%
Summary
- Current Value
- As of today, RDY annual EBITDA is $1.02B, up +7.69% on
- Historical Performance
- RDY annual EBITDA is up +64.73% over the past 3 years, and up +76.59% over the past 5 years
- All-Time High Comparison
- RDY annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- RDY annual EBITDA is +64.73% above its 3-year low of $621.49M reached on an earlier date
- Sector Comparison
- RDY annual EBITDA is higher than 93.81% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.02B | +7.7% | +64.7% | +76.6% | +235.8% | |
| Quarterly EBITDA | $236.37M | -8.1% | -0.4% | +43.5% | +168.7% | |
| TTM EBITDA | $725.53M | -25.3% | +7.6% | +24.0% | +137.7% | |
| Price | $13.68 | -12.7% | +29.8% | -4.2% | +86.7% | |
| PE Ratio | 16.75 | -17.8% | -12.8% | -59.5% | -48.4% | |
| Annual Revenue | $3.85B | +14.2% | +33.8% | +56.4% | +158.6% | |
| Annual EPS | $0.80 | -0.6% | +110.8% | +142.1% | +815.2% | |
| Annual EBIT | $822.04M | +6.6% | +77.6% | +103.5% | +278.1% | |
| Annual Net Income | $677.08M | +0.7% | +114.1% | +146.2% | +809.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.02B | at high | |
| 5Y | $1.02B | at high | |
| All | $1.02B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $621.49M | N/A | +64.7% |
| 5Y | $579.77M | N/A | +76.6% |
| All | $11.77M | +8595.2% |
EBITDA History
FAQ
What is the current annual EBITDA of RDY?
As of today, RDY annual EBITDA is $1.02B
What is 1-year change in RDY annual EBITDA?
RDY annual EBITDA is up +7.69% year-over-year
What is 3-year change in RDY annual EBITDA?
RDY annual EBITDA is up +64.73% over the past 3 years
How far is RDY annual EBITDA from its all-time high?
RDY annual EBITDA is currently at its all-time high
How does RDY annual EBITDA rank versus sector peers?
RDY annual EBITDA is higher than 93.81% of companies in Healthcare sector
When is RDY next annual earnings release?
As of today, the next annual earnings release for RDY has not been scheduled
Quarterly EBITDA
$236.37M$16.09M-6.37%
Summary
- Current Value
- As of today, RDY quarterly EBITDA is $236.37M, down -6.37% on
- Historical Performance
- RDY quarterly EBITDA is down -8.09% year-over-year, and down -0.42% over the past 3 years
- All-Time High Comparison
- RDY quarterly EBITDA is currently -8.09% below its historical high of $257.18M set on
- 3-Year Low Comparison
- RDY quarterly EBITDA is +22.81% above its 3-year low of $192.46M reached on
- Sector Comparison
- RDY quarterly EBITDA is higher than 92.59% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $236.37M | -6.4% | -8.1% | -0.4% | +43.5% | |
| Annual EBITDA | $1.02B | – | +7.7% | +64.7% | +76.6% | |
| TTM EBITDA | $725.53M | -2.8% | -25.3% | +7.6% | +24.0% | |
| Price | $13.68 | -2.5% | -12.7% | +29.8% | -4.2% | |
| PE Ratio | 16.75 | -2.5% | -17.8% | -12.8% | -59.5% | |
| Quarterly Revenue | $1.01B | +1.0% | +5.4% | +27.6% | +53.1% | |
| Quarterly EPS | $0.20 | -0.7% | +9.8% | +17.7% | +60.1% | |
| Quarterly EBIT | $178.52M | -9.3% | -14.9% | -9.9% | +47.9% | |
| Quarterly Net Income | $163.39M | -0.8% | +2.0% | +17.2% | +59.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $252.46M | -6.4% | |
| 3Y | $257.18M | -8.1% | |
| 5Y | $257.18M | -8.1% | |
| All | $257.18M | -8.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $236.37M | at low | |
| 3Y | $192.46M | +22.8% | |
| 5Y | $120.61M | +96.0% | |
| All | $1.46M | >+9999.0% |
Quarterly EBITDA History
| Month | Value | Change |
|---|---|---|
| $236.37M | -6.4% | |
| $252.46M | +6.7% | |
| $236.71M | -8.0% | |
| $257.18M | +0.5% | |
| $255.96M | +19.1% |
| Month | Value | Change |
|---|---|---|
| $214.87M | -11.7% | |
| $243.34M | +9.8% | |
| $221.55M | -11.2% | |
| $249.55M | +29.7% | |
| $192.46M | - |
FAQ
What is the current quarterly EBITDA of RDY?
As of today, RDY quarterly EBITDA is $236.37M
What is RDY quarterly EBITDA most recent change?
RDY quarterly EBITDA was down -6.37% on September 30, 2025
What is 1-year change in RDY quarterly EBITDA?
RDY quarterly EBITDA is down -8.09% year-over-year
How far is RDY quarterly EBITDA from its all-time high?
RDY quarterly EBITDA is currently -8.09% below its historical high of $257.18M set on September 30, 2024
How does RDY quarterly EBITDA rank versus sector peers?
RDY quarterly EBITDA is higher than 92.59% of companies in Healthcare sector
When is RDY next earnings release?
The next earnings release for RDY is on
TTM EBITDA
$725.53M$20.81M-2.79%
Summary
- Current Value
- As of today, RDY TTM EBITDA is $725.53M, down -2.79% on
- Historical Performance
- RDY TTM EBITDA is down -25.31% year-over-year, and up +7.57% over the past 3 years
- All-Time High Comparison
- RDY TTM EBITDA is currently -25.31% below its historical high of $971.34M set on
- 3-Year Low Comparison
- RDY TTM EBITDA is at its 3-year low
- Sector Comparison
- RDY TTM EBITDA is higher than 91.87% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $725.53M | -2.8% | -25.3% | +7.6% | +24.0% | |
| Annual EBITDA | $1.02B | – | +7.7% | +64.7% | +76.6% | |
| Quarterly EBITDA | $236.37M | -6.4% | -8.1% | -0.4% | +43.5% | |
| Price | $13.68 | -2.5% | -12.7% | +29.8% | -4.2% | |
| PE Ratio | 16.75 | -2.5% | -17.8% | -12.8% | -59.5% | |
| TTM Revenue | $3.98B | +1.3% | +10.6% | +37.3% | +61.2% | |
| TTM EPS | $0.82 | +2.2% | +6.5% | +70.2% | +232.6% | |
| TTM EBIT | $765.91M | -3.9% | -2.8% | +48.2% | +84.4% | |
| TTM Net Income | $677.57M | +0.5% | +4.2% | +69.8% | +231.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $749.85M | -3.2% | |
| 3Y | $971.34M | -25.3% | |
| 5Y | $971.34M | -25.3% | |
| All | $971.34M | -25.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $725.53M | at low | |
| 3Y | $725.53M | at low | |
| 5Y | $579.16M | +25.3% | |
| All | $15.84M | +4479.3% |
TTM EBITDA History
| Month | Value | Change |
|---|---|---|
| $725.53M | -2.8% | |
| $746.35M | -0.5% | |
| $749.85M | -22.8% | |
| $971.34M | +3.8% | |
| $935.72M | +0.7% |
| Month | Value | Change |
|---|---|---|
| $929.30M | +2.5% | |
| $906.89M | -0.9% | |
| $914.69M | -1.7% | |
| $930.50M | +16.1% | |
| $801.56M | - |
FAQ
What is the current TTM EBITDA of RDY?
As of today, RDY TTM EBITDA is $725.53M
What is RDY TTM EBITDA most recent change?
RDY TTM EBITDA was down -2.79% on September 30, 2025
What is 1-year change in RDY TTM EBITDA?
RDY TTM EBITDA is down -25.31% year-over-year
How far is RDY TTM EBITDA from its all-time high?
RDY TTM EBITDA is currently -25.31% below its historical high of $971.34M set on September 30, 2024
How does RDY TTM EBITDA rank versus sector peers?
RDY TTM EBITDA is higher than 91.87% of companies in Healthcare sector
When is RDY next earnings release?
The next earnings release for RDY is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RDY Official Website www.drreddys.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1135951/000157587225000633/0001575872-25-000633-index.html
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1135951/000157587225000393/0001575872-25-000393-index.htm
- RDY Profile on Yahoo Finance finance.yahoo.com/quote/RDY
- RDY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdy